// App-Quantinova.ai

: TP53 SOMATIC MUTATIONS AS PRE-LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Guranda Chitadze

Principal Investigators

  • Cathrin John-Klaua

  • Heiko Trautmann

  • Henrik knecht

  • Martin Schwarz

  • Michaela Kotrova

  • Julien Hollmann

  • Dietrich Hermann

  • Franziska Appelt

  • Thomas Theocharis

  • Karol Pal

  • Nikos Darzentas

  • Hans-Heinrich Oberg

  • Dieter Kabelitz

  • Nicola Gkbuget

  • Claudia Baldus

  • Claudia Haferlach

  • Monika Brggemann

Medical Centers

  • Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany

  • Munich Leukemia Laboratory, Munich, Germany.

  • Department of Hematology,University Hospital Schleswig-Holstein,Kiel,Germany;CEITEC-Central European Institute of Technology,Masaryk University,Brno,Czech Republic

  • Department of Hematology,University Hospital Schleswig-Holstein,Kiel,Germany;CEITEC-Central European Institute of Technology,Masaryk University,Brno,Czech Republic

  • Department of Medicine II, University Hospital Goethe, Frankfurt, Germany

Locations

  • Germany

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • TP53

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A